Mutya Harsch's Net Worth
$154 Thousand
Who is Mutya Harsch?
Mutya Harsch does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Foamix Pharmaceuticals Ltd., VYNE Therapeutics Inc., and Satsuma Pharmaceuticals, Inc..
SEC CIK
Mutya Harsch's CIK is 0001727809
Past Insider Trading and Trends
2023 was Mutya Harsch's most active year for acquiring shares with 4 total transactions. Mutya Harsch's most active month to acquire stocks was the month of January. 2020 was Mutya Harsch's most active year for disposing of shares, totalling 5 transactions. Mutya Harsch's most active month to dispose stocks was the month of February. 2018 saw Mutya Harsch paying a total of $317,500.00 for 75,000 shares, this is the most they've acquired in one year. In 2019 Mutya Harsch cashed out on 4,239 shares for a total of $14,396.35, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Foamix Pharmaceuticals Ltd. No price found
CLO and General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -98.23K |
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +1.83% | 1.76K |
$2.68 | $4,715.08 | 98.23K |
Mar 2
| |||
Form 4
| +74.85% | 41.3K |
—
|
—
| 96.47K |
Feb 24
| |||
Form 4
| -1.11% | -618.00 |
$3.28 | -$2,027.04 | 55.17K |
Dec 31
| |||
Form 4
| +8.32% | 4.28K |
$2.16 | $9,249.16 | 55.79K |
Nov 29
| |||
Form 4
| -0.89% | -463.00 |
$3.07 | -$1,421.41 | 51.51K |
Sep 30
| |||
Form 4
| -1.21% | -639.00 |
$2.35 | -$1,501.65 | 51.97K |
Jul 1
| |||
Form 4
| -4.57% | -2.52K |
$3.75 | -$9,446.25 | 52.61K |
Apr 1
| |||
Form 4
| +120.51% | 30.13K |
—
|
—
| 55.13K |
Jan 1
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VYNE Therapeutics Inc. (VYNE) Snapshot price: $2.11
CHIEF LEGAL OFFICER AND GC
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.11% | -161.00 |
$3.08 | -$495.88 | 149.27K |
Apr 1
| |||
Form 4
| +71.58% | 62.34K |
$2.28 | -$367.08 | 149.44K |
Jan 1 - Jan 2
| |||
Form 4
| +254.11% | 62.5K |
—
|
—
| 87.1K |
Dec 13
| |||
Form 4
| -4.48% | -1.15K |
$3.83 | -$4,419.82 | 24.6K |
Oct 2
| |||
Form 4
| -0.61% | -157.00 |
$4.10 | -$643.70 | 25.75K |
Jun 30
| |||
Form 4
| +16.47% | 3.66K |
$3.46 | $12,663.88 | 25.91K |
May 31
| |||
Form 4
| -2.10% | -478.00 |
$3.08 | -$1,472.24 | 22.24K |
Mar 31
| |||
Form 4
| +78.61% | 10K |
$2.50 | $25,000.00 | 22.72K |
Mar 20
| |||
Form 4
| -0.78% | -1.81K |
$0.15 | -$271.95 | 229.14K |
Dec 31
| |||
Form 4
| -0.78% | -1.81K |
$0.22 | -$404.30 | 230.96K |
Sep 30
| |||
Form 4
| -0.77% | -1.81K |
$0.39 | -$705.26 | 232.77K |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Satsuma Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||